STU:WSG (Hong Kong)
Â
Ordinary Shares
€
0.50
(-0.4%)
May 10
Business Description
China Traditional Chinese Medicine Holdings Co Ltd
ISIN : HK0000056256
Share Class Description:
STU:WSG: Ordinary SharesCompare
Compare
Traded in other countries / regions
00570.Hong KongWSG.GermanyCHIZF.USA IPO Date
2015-10-16Description
China Traditional Chinese Medicine Holdings Co Ltd is engaged in the Chinese healthcare sector. The company functions through five segments, Yi Fang segment, Tian Jiang segment, Tong Ji Tang segment and Medi-World segment. It generates maximum revenue from the Yifang segment. Geographically, it derives a majority of its revenue from Mainland China.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.76 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.24 | |||||
| Debt-to-EBITDA | 3.63 | |||||
| Interest Coverage | 6.83 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.18 | |||||
| Beneish M-Score | -2.37 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.1 | |||||
| 3-Year EBITDA Growth Rate | -9.3 | |||||
| 3-Year EPS without NRI Growth Rate | -11.4 | |||||
| 3-Year Book Growth Rate | 2.6 | |||||
| Future 3-5Y Total Revenue Growth Rate | 18.81 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.36 | |||||
| 9-Day RSI | 44.87 | |||||
| 14-Day RSI | 49.67 | |||||
| 6-1 Month Momentum % | 19.32 | |||||
| 12-1 Month Momentum % | 2.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.12 | |||||
| Quick Ratio | 1.48 | |||||
| Cash Ratio | 0.42 | |||||
| Days Inventory | 244.11 | |||||
| Days Sales Outstanding | 183.26 | |||||
| Days Payable | 97.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.22 | |||||
| Dividend Payout Ratio | 0.18 | |||||
| 3-Year Dividend Growth Rate | -0.6 | |||||
| Forward Dividend Yield % | 1.22 | |||||
| 5-Year Yield-on-Cost % | 0.47 | |||||
| Shareholder Yield % | 2.67 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 51.18 | |||||
| Operating Margin % | 7.5 | |||||
| Net Margin % | 7.09 | |||||
| FCF Margin % | 3.73 | |||||
| ROE % | 6.19 | |||||
| ROA % | 3.45 | |||||
| ROIC % | 5.5 | |||||
| ROC (Joel Greenblatt) % | 8.16 | |||||
| ROCE % | 5.25 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 15.41 | |||||
| PE Ratio without NRI | 15.41 | |||||
| Shiller PE Ratio | 13.41 | |||||
| Price-to-Owner-Earnings | 37.07 | |||||
| PS Ratio | 1.09 | |||||
| PB Ratio | 0.94 | |||||
| Price-to-Tangible-Book | 1.6 | |||||
| Price-to-Free-Cash-Flow | 29.05 | |||||
| Price-to-Operating-Cash-Flow | 16.93 | |||||
| EV-to-EBIT | 14.78 | |||||
| EV-to-Forward-EBIT | 10.06 | |||||
| EV-to-EBITDA | 14.78 | |||||
| EV-to-Forward-EBITDA | 6.79 | |||||
| EV-to-Revenue | 1.16 | |||||
| EV-to-Forward-Revenue | 0.87 | |||||
| EV-to-FCF | 30.93 | |||||
| Price-to-Projected-FCF | 1.08 | |||||
| Price-to-Median-PS-Value | 0.55 | |||||
| Price-to-Graham-Number | 1.06 | |||||
| Price-to-Net-Current-Asset-Value | 4.96 | |||||
| Earnings Yield (Greenblatt) % | 6.77 | |||||
| FCF Yield % | 3.44 | |||||
| Forward Rate of Return (Yacktman) % | -3.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
China Traditional Chinese Medicine Holdings Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2,331.607 | ||
| EPS (TTM) (€) | 0.033 | ||
| Beta | 0.05 | ||
| Volatility % | 63.82 | ||
| 14-Day RSI | 49.67 | ||
| 14-Day ATR (€) | 0.002915 | ||
| 20-Day SMA (€) | 0.49975 | ||
| 12-1 Month Momentum % | 2.07 | ||
| 52-Week Range (€) | 0.324 - 0.505 | ||
| Shares Outstanding (Mil) | 5,035.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
China Traditional Chinese Medicine Holdings Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
China Traditional Chinese Medicine Holdings Co Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
China Traditional Chinese Medicine Holdings Co Ltd Frequently Asked Questions
What is China Traditional Chinese Medicine Holdings Co Ltd(STU:WSG)'s stock price today?
The current price of STU:WSG is €0.50. The 52 week high of STU:WSG is €0.51 and 52 week low is €0.32.
When is next earnings date of China Traditional Chinese Medicine Holdings Co Ltd(STU:WSG)?
The next earnings date of China Traditional Chinese Medicine Holdings Co Ltd(STU:WSG) is .
Does China Traditional Chinese Medicine Holdings Co Ltd(STU:WSG) pay dividends? If so, how much?
The Dividend Yield %  of China Traditional Chinese Medicine Holdings Co Ltd(STU:WSG) is 1.22% (As of Today), Highest Dividend Payout Ratio of China Traditional Chinese Medicine Holdings Co Ltd(STU:WSG) was 0.48. The lowest was 0.13. And the median was 0.26. The  Forward Dividend Yield % of China Traditional Chinese Medicine Holdings Co Ltd(STU:WSG) is 1.22%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers